** Shares of Clarity Pharmaceuticals CU6.AX down 15% to A$3.025, top losers on the S&P/ASX 200 .AXJO benchmark index
** Stock falls as much as 26% to A$2.644 earlier in the day, their lowest level since April 30, 2024
** Radiopharmaceutical co said on Friday HY loss attributable widened to A$23 mln ($14.30 mln) from A$17 mln a year earlier
** Five mln shares change hands, 3.4 times the 30-day average of 1.5 mln
** Stock down 27.6% YTD, including current session's moves
($1 = 1.6080 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.